Zymeworks inc.

Major-Pharmaceuticals

ZYME


1385 West 8th Avenue
Vancouver , BC V6H 3V9

Executive/
Director

Price

  • Last Close
  • $ 15
    $ +0.23 1.56 %
    Jan 3, 2025
  • 52-Week High/Low
  • $12.9 - $6.18
  • YTD
  • 2.4%

  • Trading Volume
  • 24,053
  • Market Cap Full
  • $ 1.1B
  • Shares Outstanding
  • 70M
    Nov 6, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - 58.4% 10.2% -5% -33.8% -60% 15% 0.6% 2.4%
Q2 - -35.8% 22.5% 35.2% 4% 9.9% -19.1% -4.4% -15.1% -
Q3 - -4.4% 4.4% 7% 8% -16.3% 16% -26.6% 12% -
Q4 - -8% -4.9% 86.8% 3.9% -43.6% 27.8% 67.9% -12.5% -
J F M A M J J A S O N D
2025 2.4% - - - - - - - - - - -
2024 4.3% 10.8% -13% -15.5% -4.1% -0.8% 24.5% 12% - - - 4.1%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%93%206%6%-66%-52%32%41%2%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 1.13 -0.83 -0.43 -0.64 -0.87 -1.19 -0.37
Q2 - 0.63 -0.22 -0.89 -0.77 -1.31 -0.97 -0.76
Q3 - 0.65 -0.59 -0.7 -1.43 -1.25 - -0.41
Q4 - 1.28 0.38 -1.81 -0.74 -1.18 4.78 -
A 0 3.7 -1.3 -3.8 -3.6 -4.6 1.9 -1.54

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2022 2023
Mar - 64
Jun - 64.2
Sep - 67.8
Dec 63 70

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 7 0.5 0.7 1 2
Total Asset Turnover 0.6 0.1 0.1 0.1 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 18.7 1 31.2 25.2 -8.3
Equity multiplier 0.1 0.2 0.1 0.1 0.1